Nasdaq Biotechnology extensive list

Nasdaq Biotechnology extensive list
  • Pininvest Analysis

The NASDAQ Biotechnology theme offers an extensive selection of biotech firms listed on the stock exchange

For comparison purposes, the iShares Nasdaq Biotechnology ETF IBB seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ

The iShares fund offers a well-regarded sector view on U.S. biotechnology and pharmaceutical companies

Note from Pininvest

The biotech selection of the theme is not weighted; performance and volatility are calculated for informative purpose only - assuming one share of each component had been invested at the beginning of the selected period

Actual performance of IBB, the tracker fund, which maybe higher or lower, depending on the weighting and trades decided by the provider, please check the information available on the iShares Nasdaq Biotechnology  ETF site or contact your advisor

Nasdaq Biotechnology extensive list • Updated:

Name Ticker Exchange Category SubCategory Currency Cur.Price AUM Perf. Vol. Risk Contrib. MDD
 
AC Immune ACIU NASDAQ - - USD 9.20 622 M -18.9% 120%   0% -68%
ACADIA Pharmaceuticals Inc ACAD NASDAQ - - USD 43.43 6.7 B 106.1% 71%   1% -21%
Acceleron Pharma XLRN NASDAQ - - USD 56.14 3.0 B 37.0% 42%   1% -20%
AcelRx Pharmaceuticals ACRX NASDAQ - - USD 1.90 151 M -24.3% 62%   0% -58%
Achillion Pharmaceuticals ACHN NASDAQ - - USD 6.19 867 M 182.6% 76%   1% -26%
Aclaris Therapeutics ACRS NASDAQ - - USD 1.84 76 M -71.1% 124%   0% -89%
Acorda Therapeutics Inc ACOR NASDAQ - - USD 2.07 99 M -87.3% 118%   0% -91%
Adamas Pharmaceuticals Inc ADMS NASDAQ - - USD 5.88 1.5 B -34.8% 96%   0% -72%
Adaptimmune Therapeutics ADAP NASDAQ - - USD 4.52 476 M -7.0% 141%   1% -87%
Aduro Biotech ADRO NASDAQ - - USD 1.40 - -48.1% 85%   0% -79%
Adverum Biotechnologies ADVM NASDAQ - - USD 11.72 757 M 261.7% 104%   2% -68%
Aeglea BioTherapeutics AGLE NASDAQ - - USD 7.94 230 M -11.0% 49%   0% -35%
Aerie Pharmaceuticals AERI NASDAQ - - USD 22.74 1.1 B -48.3% 62%   0% -64%
Agios Pharmaceuticals AGIO NASDAQ - - USD 52.86 3.1 B -5.4% 48%   0% -56%
Aimmune Therapeutics AIMT NASDAQ - - USD 34.92 2.2 B 52.5% 47%   1% -29%
Akcea Therapeutics AKCA NASDAQ - - USD 17.05 1.6 B -43.3% 66%   0% -57%
Akebia Therapeutics, Inc. AKBA NASDAQ - - USD 8.03 955 M 25.7% 74%   1% -64%
Akorn AKRX NASDAQ - - USD 1.35 170 M -62.4% 86%   0% -76%
Alexion Pharmaceuticals Inc. ALXN NASDAQ - - USD 113.27 25 B -3.2% 36%   0% -33%
Alkermes Inc. ALKS NASDAQ - - USD 19.24 3.0 B -43.6% 42%   0% -54%
Allakos ALLK NASDAQ - - USD 83.07 4.0 B 95.6% 101%   0% -40%
Alnylam Pharmaceuticals ALNY NASDAQ - - USD 118.82 13 B 42.9% 41%   0% -30%
AMAG Pharmaceuticals Inc AMAG NASDAQ - - USD 11.84 402 M -30.6% 65%   0% -52%
Amarin Corporation AMRN NASDAQ - - USD 19.91 7.1 B 15.6% 61%   0% -40%
Amgen Inc. AMGN NASDAQ - - USD 241.49 143 B 21.3% 20%   0% -18%
Amicus Therapeutics Inc. FOLD NASDAQ - - USD 10.41 2.7 B -15.4% 47%   0% -48%
Amphastar Pharmaceuticals Inc AMPH NASDAQ - - USD 20.08 943 M -8.5% 32%   0% -32%
Amyris AMRS NASDAQ - - USD 2.97 313 M -17.3% 112%   0% -67%
AnaptysBio ANAB NASDAQ - - USD 15.88 431 M -78.3% 138%   0% -87%
ANI Pharmaceuticals ANIP NASDAQ - - USD 61.27 741 M 12.1% 41%   0% -37%
Apellis Pharmaceuticals APLS NASDAQ - - USD 40.50 2.6 B 172.2% 64%   1% -31%
Aptinyx APTX NASDAQ - - USD 4.60 155 M -12.2% 70%   0% -53%
Aquestive Therapeutics AQST NASDAQ - - USD 4.10 103 M -40.8% 100%   0% -62%
Arbutus Biopharma ABUS NASDAQ - - USD 3.07 175 M -16.8% 102%   0% -81%
Ardelyx ARDX NASDAQ - - USD 7.14 449 M 220.2% 91%   1% -33%
Arena Pharmaceuticals ARNA NASDAQ - - USD 46.67 2.3 B 8.1% 36%   0% -29%
argenx SE ARGX NASDAQ - - USD 154.39 5.6 B 51.3% 36%   0% -29%
ArQule Inc. ARQL NASDAQ - - USD 20.00 2.4 B 434.8% 111%   3% -41%
Arrowhead Pharmaceuticals ARWR NASDAQ - - USD 56.42 5.4 B 288.6% 60%   2% -23%
Ascendis Pharma ASND NASDAQ - - USD 139.13 5.9 B 88.3% 68%   0% -31%
Asertio Therapeutics ASRT NASDAQ - - USD 1.24 100 M -70.3% 115%   0% -88%
Atara Biotherapeutics ATRA NASDAQ - - USD 15.03 814 M -59.7% 62%   0% -74%
Athenex ATNX NASDAQ - - USD 15.27 1.2 B 26.7% 68%   0% -54%
Audentes Therapeutics BOLD NASDAQ - - USD 59.97 2.7 B 144.2% 86%   1% -38%
Aurinia Pharmaceuticals AUPH NASDAQ - - USD 20.08 1.7 B 166.0% 80%   1% -49%
Autolus Therapeutics AUTL NASDAQ - - USD 12.55 504 M -59.6% 76%   0% -69%
Avadel Pharmaceuticals (ADR) AVDL NASDAQ - - USD 7.63 286 M 199.2% 100%   0% -67%
AVROBIO AVRO NASDAQ - - USD 22.78 721 M 70.5% 74%   1% -52%
Axovant Sciences AXGT NASDAQ - - USD 4.43 101 M -45.2% 80%   0% -72%
BeiGene BGNE NASDAQ - - USD 170.36 10 B 18.9% 53%   0% -23%
Bellicum Pharmaceuticals BLCM NASDAQ - - USD 2.29 114 M -32.2% 106%   0% -81%
Bio-Techne TECH NASDAQ - - USD 220.61 8.4 B 35.8% 24%   0% -15%
BioCryst Pharmaceuticals BCRX NASDAQ - - USD 2.78 307 M -70.4% 101%   0% -84%
Biogen BIIB NASDAQ - - USD 285.50 52 B -15.4% 48%   0% -36%
BioMarin Pharmaceutical BMRN NASDAQ - - USD 88.27 16 B -9.6% 29%   0% -35%
bluebird bio, Inc. BLUE NASDAQ - - USD 98.04 5.4 B -24.6% 50%   0% -55%
Blueprint Medicines Corp BPMC NASDAQ - - USD 81.10 4.0 B 15.8% 49%   0% -34%
Calithera Biosciences CALA NASDAQ - - USD 7.41 398 M 66.1% 74%   1% -63%
Calyxt CLXT NASDAQ - - USD 7.30 240 M -37.4% 75%   0% -81%
Cara Therapeutics CARA NASDAQ - - USD 17.31 808 M 12.7% 65%   0% -44%
Cellectis (ADR) CLLS NASDAQ - - USD 18.24 774 M 9.0% 46%   0% -53%
Cerus Corporation CERS NASDAQ - - USD 4.07 578 M -28.3% 44%   0% -44%
ChemoCentryx, Inc. CCXI NASDAQ - - USD 43.66 2.5 B 250.7% 146%   2% -56%
Chimerix CMRX NASDAQ - - USD 2.04 125 M -24.4% 78%   0% -70%
China Biologic Products Inc. CBPO NASDAQ - - USD 115.80 4.6 B 42.6% 19%   0% -12%
Clovis Oncology, Inc. CLVS NASDAQ - - USD 9.85 540 M -59.0% 117%   0% -90%
Coherus BioSciences CHRS NASDAQ - - USD 19.16 1.3 B 63.5% 57%   0% -30%
Collegium Pharmaceutical COLL NASDAQ - - USD 23.41 785 M 48.5% 61%   0% -45%
Concert Pharmaceuticals CNCE NASDAQ - - USD 10.42 248 M -26.7% 73%   0% -67%
Corbus Pharmaceuticals Holdings CRBP NASDAQ - - USD 7.01 453 M -6.9% 54%   0% -52%
Corvus Pharmaceuticals CRVS NASDAQ - - USD 5.70 168 M 38.3% 94%   1% -61%
Crinetics Pharmaceuticals CRNX NASDAQ - - USD 23.79 576 M 3.4% 50%   0% -46%
CRISPR Therapeutics CRSP NASDAQ - - USD 58.33 3.2 B 57.1% 62%   1% -30%
Curis Inc. CRIS NASDAQ - - USD 1.71 57 M 47.4% 87%   0% -52%
Cymabay Therapeutics CBAY NASDAQ - - USD 2.02 139 M -77.4% 167%   0% -90%
Cytokinetics Inc. CYTK NASDAQ - - USD 12.14 717 M 77.2% 62%   1% -44%
CytomX Therapeutics CTMX NASDAQ - - USD 7.46 339 M -55.5% 70%   0% -73%
DBV Technologies (ADR) DBVT NASDAQ - - USD 12.67 382 M 79.0% 56%   1% -37%
Deciphera Pharmaceuticals DCPH NASDAQ - - USD 69.40 3.5 B 159.4% 79%   1% -18%
Denali Therapeutics DNLI NASDAQ - - USD 22.36 2.1 B 3.8% 58%   0% -49%
Dermira DERM NASDAQ - - USD 19.16 1.0 B 182.1% 94%   2% -64%
Dicerna Pharmaceuticals DRNA NASDAQ - - USD 21.36 1.5 B 98.3% 52%   1% -26%
Eagle Pharmaceuticals Inc EGRX NASDAQ - - USD 58.97 806 M 32.8% 37%   0% -16%
Editas Medicine EDIT NASDAQ - - USD 30.64 1.6 B 17.2% 55%   1% -30%
Eidos Therapeutics EIDX NASDAQ - - USD 55.39 2.1 B 337.9% 67%   1% -29%
Eiger BioPharmaceuticals EIGR NASDAQ - - USD 14.09 345 M 2.0% 48%   0% -36%
Eloxx Pharmaceuticals ELOX NASDAQ - - USD 4.47 179 M -61.4% 112%   0% -77%
Enanta Pharmaceuticals Inc ENTA NASDAQ - - USD 57.94 1.1 B -24.7% 41%   0% -45%
Endo Pharmaceuticals Holdings Inc. ENDP NASDAQ - - USD 6.04 1.4 B -37.7% 96%   0% -80%
Epizyme, Inc. EPZM NASDAQ - - USD 26.72 2.4 B 179.5% 62%   1% -35%
Esperion Therapeutics ESPR NASDAQ - - USD 57.43 1.6 B 33.4% 45%   0% -36%
Evolus EOLS NASDAQ - - USD 11.29 310 M -29.3% 78%   0% -63%
Exelixis EXEL NASDAQ - - USD 19.82 6.0 B -12.5% 38%   0% -39%
EyePoint Pharmaceuticals EYPT NASDAQ - - USD 1.70 184 M -24.8% 77%   0% -54%
Fate Therapeutics FATE NASDAQ - - USD 25.65 1.9 B 59.9% 70%   1% -40%
FibroGen FGEN NASDAQ - - USD 44.35 3.9 B -15.9% 50%   0% -42%
Five Prime Therapeutics FPRX NASDAQ - - USD 5.31 193 M -52.5% 65%   0% -77%
Flexion Therapeutics FLXN NASDAQ - - USD 17.51 668 M 20.1% 57%   0% -39%
Foamix Pharmaceuticals FOMX NASDAQ - - USD 4.70 288 M 27.0% 63%   0% -54%
Forty Seven FTSV NASDAQ - - USD 45.74 1.9 B 216.1% 104%   2% -71%
G1 Therapeutics GTHX NASDAQ - - USD 25.36 953 M 26.0% 84%   1% -49%
Galapagos GLPG NASDAQ - - USD 227.69 12 B 117.4% 38%   0% -22%
Genomic Health GHDX NASDAQ - - USD 63.44 2.4 B -12.7% 35%   0% -39%
Geron GERN NASDAQ - - USD 1.41 282 M 29.4% 56%   0% -43%
Gilead Sciences GILD NASDAQ - - USD 62.98 80 B -5.3% 21%   0% -12%
Global Blood Therapeutics GBT NASDAQ - - USD 83.76 5.0 B 71.4% 45%   1% -28%
GlycoMimetics GLYC NASDAQ - - USD 4.89 212 M -54.8% 134%   0% -79%
Grifols SA GRFS NASDAQ - - USD 23.64 16 B 24.8% 21%   0% -14%
GW Pharmaceuticals (ADR) GWPH NASDAQ - - USD 118.97 3.7 B -13.3% 46%   0% -49%
Halozyme Therapeutics HALO NASDAQ - - USD 19.97 2.9 B 21.5% 32%   0% -16%
Homology Medicines FIXX NASDAQ - - USD 17.34 764 M -24.1% 62%   0% -62%
Horizon Pharma PLC HZNP NASDAQ - - USD 38.40 7.2 B 75.8% 43%   0% -21%
Hutchison China MediTech HCM NASDAQ - - USD 29.41 3.9 B 32.8% 52%   0% -46%
Illumina ILMN NASDAQ - - USD 324.72 48 B 3.8% 33%   0% -29%
Immunogen IMGN NASDAQ - - USD 4.56 683 M -10.6% 111%   0% -70%
Immunomedics, Inc. IMMU NASDAQ - - USD 19.01 3.7 B 42.8% 61%   1% -38%
Incyte Corporation INCY NASDAQ - - USD 80.50 17 B 2.7% 31%   0% -20%
Innoviva INVA NASDAQ - - USD 14.43 1.5 B -26.6% 34%   0% -50%
Inovio Pharmaceuticals INO NASDAQ - - USD 3.29 329 M -35.4% 70%   0% -61%
Insmed INSM NASDAQ - - USD 21.46 1.9 B -10.5% 49%   0% -52%
Intellia Therapeutics NTLA NASDAQ - - USD 14.63 715 M -3.7% 58%   1% -44%
Intercept Pharmaceuticals ICPT NASDAQ - - USD 106.11 3.5 B -6.5% 51%   0% -52%
Intra-Cellular Therapies, Inc. ITCI NASDAQ - - USD 26.25 1.5 B 109.2% 129%   1% -34%
Intrexon XON NASDAQ - - USD 5.83 - -34.0% 86%   0% -53%
Ionis Pharmaceuticals IONS NASDAQ - - USD 60.13 8.5 B 3.6% 38%   0% -37%
Iovance Biotherapeutics IOVA NASDAQ - - USD 23.88 3.0 B 153.5% 66%   1% -31%
Ironwood Pharmaceuticals IRWD NASDAQ - - USD 12.60 2.0 B 15.3% 48%   0% -46%
Jazz Pharmaceuticals JAZZ NASDAQ - - USD 151.05 8.5 B 17.0% 27%   0% -19%
Jounce Therapeutics JNCE NASDAQ - - USD 7.24 241 M 90.5% 79%   1% -59%
Kala Pharmaceuticals KALA NASDAQ - - USD 6.52 225 M 10.7% 75%   0% -63%
Karyopharm Therapeutics Inc. KPTI NASDAQ - - USD 17.04 1.1 B 72.8% 89%   1% -58%
Kiniksa Pharmaceuticals KNSA NASDAQ - - USD 15.45 848 M -35.5% 75%   0% -79%
Kura Oncology KURA NASDAQ - - USD 12.76 578 M -19.5% 44%   0% -39%
Lexicon Pharmaceuticals LXRX NASDAQ - - USD 4.04 429 M -32.2% 153%   0% -85%
Ligand Pharmaceuticals LGND NASDAQ - - USD 90.39 1.6 B -23.3% 41%   0% -33%
Luminex Corp LMNX NASDAQ - - USD 23.18 1.0 B -11.8% 33%   0% -38%
MacroGenics MGNX NASDAQ - - USD 11.26 551 M -8.5% 99%   0% -69%
Magenta Therapeutics MGTA NASDAQ - - USD 14.12 551 M 101.7% 81%   1% -54%
MannKind Corporation MNKD NASDAQ - - USD 1.51 312 M 7.1% 59%   0% -54%
Marinus Pharmaceuticals MRNS NASDAQ - - USD 2.26 122 M -29.8% 155%   0% -81%
Medicines Co MDCO NASDAQ - - USD 84.90 6.8 B 324.5% 47%   1% -18%
MediciNova Inc. MNOV NASDAQ - - USD 6.97 306 M -29.0% 63%   0% -51%
Medpace Holdings MEDP NASDAQ - - USD 90.95 3.3 B 48.2% 41%   0% -27%
Mersana Therapeutics MRSN NASDAQ - - USD 8.05 385 M 117.0% 90%   1% -80%
Minerva Neurosciences NERV NASDAQ - - USD 8.36 326 M 18.2% 75%   0% -53%
Mirati Therapeutics, Inc. MRTX NASDAQ - - USD 97.05 3.8 B 49.5% 63%   1% -35%
Momenta Pharmaceuticals MNTA NASDAQ - - USD 30.60 3.0 B 151.6% 55%   1% -36%
Mylan MYL NASDAQ - - USD 21.66 11 B -26.8% 49%   0% -48%
MyoKardia MYOK NASDAQ - - USD 73.74 3.4 B 62.0% 41%   1% -19%
Myriad Genetics MYGN NASDAQ - - USD 28.72 2.1 B -3.2% 102%   0% -56%
Nabriva Therapeutics NBRV NASDAQ - - USD 1.47 1.2 B -25.4% 74%   0% -62%
NanoString Technologies NSTG NASDAQ - - USD 30.80 1.1 B 52.1% 48%   0% -38%
NantHealth NH NASDAQ - - USD 1.44 159 M 105.7% 114%   1% -65%
NantKwest, Inc. NK NASDAQ - - USD 7.35 723 M 444.4% 123%   2% -28%
Nektar Therapeutics NKTR NASDAQ - - USD 22.48 4.0 B -51.3% 70%   0% -66%
Neos Therapeutics NEOS NASDAQ - - USD 1.60 80 M -22.0% 68%   0% -65%
Neurocrine Biosciences NBIX NASDAQ - - USD 104.67 10 B 14.4% 36%   0% -21%
Neuronetics STIM NASDAQ - - USD 4.39 82 M -69.5% 79%   0% -78%
NewLink Genetics NLNK NASDAQ - - USD 2.04 521 M 34.2% 81%   0% -37%
Novavax NVAX NASDAQ - - USD 5.74 153 M -86.0% 142%   0% -92%
NovoCure NVCR NASDAQ - - USD 92.58 9.2 B 99.3% 45%   1% -30%
Ocular Therapeutix OCUL NASDAQ - - USD 4.63 223 M 17.5% 79%   0% -52%
Omeros Corp OMER NASDAQ - - USD 13.64 678 M 1.5% 50%   0% -37%
OPKO Health OPK NASDAQ - - USD 1.56 1.0 B -58.9% 58%   0% -63%
OptiNose OPTN NASDAQ - - USD 8.57 356 M 19.5% 71%   0% -57%
Pacific Biosciences of California PACB NASDAQ - - USD 4.98 762 M -32.2% 32%   0% -38%
Pacira Pharmaceuticals PCRX NASDAQ - - USD 43.82 1.8 B 9.4% 35%   0% -26%
Paratek Pharmaceuticals PRTK NASDAQ - - USD 3.64 121 M -45.8% 79%   0% -60%
PDL BioPharma PDLI NASDAQ - - USD 3.26 372 M 4.5% 44%   0% -45%
PetIQ PETQ NASDAQ - - USD 30.74 869 M 10.8% 50%   0% -38%
Portola Pharmaceuticals PTLA NASDAQ - - USD 14.37 1.1 B -45.8% 67%   0% -63%
PRA Health Sciences PRAH NASDAQ - - USD 106.17 6.7 B 4.4% 26%   0% -25%
Progenics Pharmaceuticals PGNX NASDAQ - - USD 4.69 405 M -4.5% 57%   0% -43%
ProQR Therapeutics PRQR NASDAQ - - USD 8.04 313 M -47.9% 66%   0% -66%
Proteostasis Therapeutics PTI NASDAQ - - USD 1.96 - -37.2% 180%   0% -86%
Prothena Corp plc PRTA NASDAQ - - USD 14.26 569 M 19.1% 57%   0% -52%
PTC Therapeutics PTCT NASDAQ - - USD 53.80 3.3 B 56.2% 41%   1% -33%
Puma Biotechnology PBYI NASDAQ - - USD 9.73 379 M -61.4% 95%   0% -85%
Quanterix QTRX NASDAQ - - USD 24.09 675 M 14.6% 58%   0% -45%
Ra Pharmaceuticals RARX NASDAQ - - USD 46.97 2.2 B 134.9% 86%   1% -37%
Radius Health RDUS NASDAQ - - USD 19.65 907 M 12.2% 52%   0% -38%
Reata Pharmaceuticals RETA NASDAQ - - USD 211.43 6.4 B 174.1% 68%   1% -15%
Regeneron Pharmaceuticals REGN NASDAQ - - USD 385.94 42 B -7.9% 28%   0% -38%
REGENXBIO RGNX NASDAQ - - USD 48.19 1.8 B 2.3% 59%   1% -49%
Repligen RGEN NASDAQ - - USD 100.71 5.2 B 72.7% 39%   1% -23%
Replimune Group REPL NASDAQ - - USD 18.93 606 M 81.1% 77%   1% -42%
resTORbio TORC NASDAQ - - USD 1.46 53 M -83.1% 210%   0% -91%
Retrophin RTRX NASDAQ - - USD 16.17 695 M -27.2% 46%   0% -54%
Revance Therapeutics, Inc. RVNC NASDAQ - - USD 22.47 1.0 B 26.1% 51%   0% -43%
Rhythm Pharmaceuticals RYTM NASDAQ - - USD 19.70 865 M -34.4% 49%   0% -41%
Rigel Pharmaceuticals RIGL NASDAQ - - USD 2.88 483 M 37.8% 58%   1% -40%
Rocket Pharmaceuticals RCKT NASDAQ - - USD 20.76 1.0 B 30.2% 61%   1% -45%
Rubius Therapeutics RUBY NASDAQ - - USD 8.92 712 M -36.1% 77%   0% -64%
SAGE Therapeutics SAGE NASDAQ - - USD 76.40 4.0 B -45.3% 99%   0% -68%
Sangamo Therapeutics SGMO NASDAQ - - USD 8.37 970 M -28.0% 70%   0% -38%
Sarepta Therapeutics SRPT NASDAQ - - USD 127.90 10 B 4.2% 58%   0% -54%
Savara SVRA NASDAQ - - USD 3.75 155 M -49.2% 208%   0% -94%
Seattle Genetics Inc. SGEN NASDAQ - - USD 109.00 19 B 48.1% 43%   0% -22%
Seres Therapeutics MCRB NASDAQ - - USD 3.43 240 M -39.9% 80%   0% -69%
SIGA Technologies Inc. SIGA NASDAQ - - USD 5.20 422 M -29.2% 37%   0% -41%
Solid Biosciences SLDB NASDAQ - - USD 3.86 178 M -85.0% 201%   0% -89%
Spark Therapeutics ONCE NASDAQ - - USD 113.57 4.4 B 151.9% 82%   1% -16%
Spectrum Pharmaceuticals Inc SPPI NASDAQ - - USD 3.24 366 M -70.3% 107%   0% -73%
Strongbridge Biopharma SBBP NASDAQ - - USD 2.74 149 M -43.3% 70%   0% -74%
Supernus Pharmaceuticals SUPN NASDAQ - - USD 24.44 1.3 B -35.8% 55%   0% -53%
Surface Oncology SURF NASDAQ - - USD 3.37 94 M -31.4% 97%   0% -80%
Syndax Pharmaceuticals SNDX NASDAQ - - USD 9.02 245 M 56.1% 64%   1% -50%
Syneos Health SYNH NASDAQ - - USD 63.99 6.6 B 29.7% 40%   0% -27%
Synlogic SYBX NASDAQ - - USD 2.98 96 M -58.8% 84%   0% -81%
Syros Pharmaceuticals SYRS NASDAQ - - USD 8.51 361 M 26.0% 90%   0% -61%
TherapeuticsMD TXMD NASDAQ - - USD 2.31 626 M -54.8% 72%   0% -69%
Theravance Biopharma TBPH NASDAQ - - USD 25.22 1.4 B -7.3% 41%   0% -43%
Tocagen TOCA NASDAQ - - USD 0.60 14 M -93.2% 183%   0% -96%
Translate Bio TBIO NASDAQ - - USD 8.04 483 M 45.4% 79%   1% -43%
Tricida TCDA NASDAQ - - USD 34.86 1.7 B 58.7% 64%   1% -30%
Ultragenyx Pharmaceutical Inc. RARE NASDAQ - - USD 59.96 3.5 B 12.4% 51%   0% -51%
uniQure QURE NASDAQ - - USD 67.53 2.9 B 115.3% 65%   1% -55%
United Therapeutics UTHR NASDAQ - - USD 93.13 4.1 B -19.5% 29%   0% -41%
Unity Biotechnology UBX NASDAQ - - USD 7.39 340 M -40.6% 63%   0% -55%
Unun Therapeutics UMRX NASDAQ - - USD 0.95 29 M -77.0% 91%   0% -89%
UroGen Pharma URGN NASDAQ - - USD 33.85 710 M -33.8% 51%   0% -61%
Vanda Pharmaceuticals VNDA NASDAQ - - USD 15.11 806 M -51.3% 52%   0% -60%
Veracyte VCYT NASDAQ - - USD 30.15 1.5 B 74.5% 54%   1% -33%
Verastem, Inc. VSTM NASDAQ - - USD 1.90 141 M -45.1% 91%   0% -76%
Vertex Pharmaceuticals VRTX NASDAQ - - USD 235.83 61 B 21.1% 26%   0% -15%
Voyager Therapeutics VYGR NASDAQ - - USD 13.79 511 M 66.9% 69%   1% -55%
WAVE Life Sciences WVE NASDAQ - - USD 7.88 270 M -81.5% 127%   0% -84%
Xencor XNCR NASDAQ - - USD 37.55 2.1 B 11.6% 52%   0% -29%
Xenon Pharmaceuticals XENE NASDAQ - - USD 17.40 450 M 127.5% 48%   1% -25%
Xeris Pharmaceuticals XERS NASDAQ - - USD 6.19 167 M -63.6% 71%   0% -67%
Zafgen ZFGN NASDAQ - - USD 1.22 46 M -74.3% 88%   0% -87%
Zai Lab ZLAB NASDAQ - - USD 53.10 3.1 B 104.2% 43%   0% -21%
Zogenix ZGNX NASDAQ - - USD 54.98 2.4 B 27.4% 45%   0% -34%